2-(5-Bromo-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

6-(4-fluorophenyl)pyridazin-3-ol, 95.0%, 1g

2-Bromo-4-chloroaniline>98.0%(GC)25g

(R)-N-(2-Acetyl-5,8-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide, 98%, 1g

6-(1-METHYL-1H-PYRAZOL-4-YL)-1-((6-(1-METHYL-1H-PYRAZOL-4-YL)IMIDAZO[1,2-A]PYRIDIN-3-YL)SULFONYL)-1H-PYRAZOLO[4,3-B]PYRIDINE, 95%, 1mg

tert-Butyl 3-nitro-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate, 95.0%, 250mg

3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)benzonitrile, 95.0%, 250mg

2-Benzyloxy-4-(trifluoromethoxy)phenylboronic acid, 98+%, 1g

Dibutyl Ether (stabilized with BHT)>99.0%(GC)25mL

BOC-ASP(OTBU), 97.0%, 100g

5-Nitro-2,4,6-triaminopyrimidine, 95%, 100mg

Isobutylene oxide, 97.0%, 500ml

Ethylene Cyanohydrin>97.0%(GC)25mL